1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Lifescan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus Rosiglitazone (Avandia) OR other diabetes medication currently prescribed to participant, conjugated linoleic acid (CLA) - Type 2 Diabetes Mellitus | Phase 1 | Completed | Ohio State University | 48 | 2008-01-01 | 2024-10-29 |
Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Weight Loss (1)
Linoleic Acids, Conjugated (1) · Rosiglitazone (1)
United States (1)
R21AT003520 (1)